Literature DB >> 17898039

Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis.

Jan-Stephan F Sanders1, Minke G Huitema, Roeland Hanemaaijer, Harry van Goor, Cees G M Kallenberg, Coen A Stegeman.   

Abstract

Renal expression of MMP-2, -9, and tissue inhibitor of MMP-1 (TIMP-1) correlates with histological disease activity in anti-neutrophil cytoplasm autoantibody (ANCA)-associated vasculitis (AAV). We studied whether urinary and plasma levels of MMP-2, -9, and TIMP-1 reflect renal expression of these proteins and renal disease-activity in AAV. Urine and plasma samples of patients with AAV who underwent a renal biopsy were collected (n = 32). Urinary activity of MMP-2 and -9 was measured by activity assays. Urinary and plasma levels of MMP-2, MMP-9, and TIMP-1 proteins were measured by ELISA. Healthy controls provided plasma and urine for comparison (n = 31). In patients, the relationship of urinary and plasma levels with renal expression of MMP-2 and MMP-9 and clinical and histological disease activity was studied. Renal MMP expression was compared between patients and controls (n = 8). Urinary MMP-2 and MMP-9 activity and urinary and plasma TIMP-1 levels were significantly higher in patients than in controls. In glomeruli of patients, both MMP-2 and MMP-9 expression reflected active glomerular inflammation. Urinary activity of MMP-2 and MMP-9 did not correlate with renal MMP expression or plasma levels. Urinary MMP activity correlated negatively with glomerular inflammation, but positively with fibrous crescents. Urinary MMP-2 and TIMP-1 levels showed a positive correlation with tubulointerstitial damage and a negative correlation with creatinine clearance. Urinary MMP-2, MMP-9, and TIMP-1 are elevated in AAV but do not reflect renal MMP expression and glomerular inflammation. However, urinary MMP-2 activity and TIMP-1 levels reflect tubulointerstitial damage and correlate negatively with creatinine clearance at biopsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898039     DOI: 10.1152/ajprenal.00310.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

1.  Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.

Authors:  W Wong; J DeVito; H Nguyen; D Sarracino; F Porcheray; I Dargon; P D Pelle; A B Collins; N Tolkoff-Rubin; R N Smith; R Colvin; E Zorn
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

2.  Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.

Authors:  Roxanne Cofiell; Anjli Kukreja; Krystin Bedard; Yan Yan; Angela P Mickle; Masayo Ogawa; Camille L Bedrosian; Susan J Faas
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

3.  urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jason G Lieberthal; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Philip Seo; Ulrich Specks; Steven R Ytterberg; Peter A Merkel; Paul A Monach
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

4.  The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients.

Authors:  Logan Eisner; Andrea Vambutas; Shresh Pathak
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

5.  Performance of novel kidney biomarkers in preclinical toxicity studies.

Authors:  Dana Hoffmann; Melanie Adler; Vishal S Vaidya; Eva Rached; Laoighse Mulrane; William M Gallagher; John J Callanan; Jean C Gautier; Katja Matheis; Frank Staedtler; Frank Dieterle; Arnd Brandenburg; Alexandra Sposny; Philip Hewitt; Heidrun Ellinger-Ziegelbauer; Joseph V Bonventre; Wolfgang Dekant; Angela Mally
Journal:  Toxicol Sci       Date:  2010-01-29       Impact factor: 4.849

6.  Matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in vesicoureteral reflux.

Authors:  Alev Yilmaz; Ilmay Bilge; Aysel Kiyak; Asuman Gedikbasi; Aysegul Sucu; Bagdagul Aksu; Sevinc Emre; Aydan Sirin
Journal:  Pediatr Nephrol       Date:  2011-10-05       Impact factor: 3.714

Review 7.  Matrix metalloproteinases in kidney homeostasis and diseases.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

8.  Urinary FSP1 is a biomarker of crescentic GN.

Authors:  Masayuki Iwano; Yukinari Yamaguchi; Takaaki Iwamoto; Kimihiko Nakatani; Masaru Matsui; Atsushi Kubo; Yasuhiro Akai; Toshio Mori; Yoshihiko Saito
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

9.  Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.

Authors:  Femke Waanders; Vishal S Vaidya; Harry van Goor; Henri Leuvenink; Kevin Damman; Inge Hamming; Joseph V Bonventre; Liffert Vogt; Gerjan Navis
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

10.  Sudden and rapid progression of lung affectation but stability in kidney function: a case report of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Cheng Chen; Ye-Han Zhu; Hong-Ying Qian; Ling-Yi Yang; Jian-An Huang
Journal:  Int Med Case Rep J       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.